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Purpose: Blocks have been used to protect heart from potential radiation damage in
left-sided breast treatments. Since cardiac motion pattern may not be fully captured on
conventional 3DCT or 4DCT simulation scans, this study was intended to investigate the
optimization of the heart block design taking the cardiac motion into consideration.
Materials and Methods: Whole breast treatment plans using two opposed tangential
fields were designed based on 4DCT simulation images for 10 left-sided breast cancer
patients. Using an OBI system equipped to a Varian Linac, beam-eye viewed fluoroscopy
images were acquired for each of the treatment beams after patient treatment setup, and
the MLC heart blocks were overlaid onto the fluoroscopy images with an in-house software
package. A non-rigid image registration and tracking algorithm was utilized to track the car-
diac motion on the fluoroscopy images with minimal manual delineation for initialization,
and the tracked cardiac motion information was used to optimize the heart block design to
minimize the radiation damage to heart while avoiding the over-shielding that may lead to
underdosing certain breast tissues.
Results: Twenty-three sets of fluoroscopy images were acquired on 23 different days of
treatment for the 10 patients. As expected, heart moved under the influences of both res-
piratory and cardiac motion. It was observed that for 16 out of the 23 treatments, heart
moved beyond the planed heart block into treatment fields and MLC had to be adjusted
to fully block heart. The adjustment was made for all but one patient. The number of the
adjusted MLC leaves ranged from 1 to 16 (mean=10), and the MLC leaf position adjust-
ment ranged from 2 to 10 mm (mean=6 mm). The added heart block areas ranged from 3
to 1230 mm2 (mean=331 mm2).
Conclusion: In left-sided whole breast radiation treatments, simulation CT (and 4DCT)
based heart block design may not provide adequate heart protection for all the treatments.
A fluoroscopy-based method has been developed to adaptively optimize the heart MLC
block to achieve optimal heart protection.
Keywords: heart block optimization, left breast radiotherapy, breast cancer, intra-fractional motion, image
processing
INTRODUCTION
Radiotherapy is an effective treatment modality for early-stage
breast cancer (1–7). However, during the treatments, especially
in left-sided patients, the heart inevitably receives a non-negligible
amount of radiation doses. Taylor et al. estimated the cardiac doses
of 358 patients received from breast cancer radiotherapy in Swe-
den during the period of time from the 1950s to the 1990s (8).
They found that in this group of patients treated with relatively
outdated technologies the mean heart dose varied from 0.1 to
23.6 Gy while the mean left anterior descending coronary artery
dose varied from 0.1 to 46.3 Gy. They also reported that heart doses
were significantly higher among the patients treated for left-sided
breast cancer than for right-sided breast cancer (respectively, 5.1
and 1.8 Gy in the 1950s, 10.5 and 4.7 Gy in the 1970s, and 3.0 and
1.9 Gy in the 1990s). It is interesting and unsurprising to notice
that the heart doses changed with the time period that was associ-
ated with technology advancement, indicating the important roles
of radiotherapy technologies in the management and reduction
of the heart doses. Many studies have shown that the heart dose
received during the breast treatments can lead to long-term side
effects and toxicities (9–15). Darby et al. conducted a population-
based case–control study of major coronary events in 2168 women
who underwent radiotherapy for breast cancer between 1958 and
2001 in Sweden and Denmark and concluded that exposure of the
heart to ionizing radiation during breast cancer radiation treat-
ment increases the subsequent rate of ischemic heart disease and
the increase is proportional to the mean dose to the heart (9). A
study by Nilsson et al. specifically investigated the distribution of
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coronary artery stenosis after radiation for breast cancer (11). They
found that stenosis in mid and distal left anterior descending artery
and distal diagonal increased in irradiated left-sided breast cancer
and an association between irradiated high risk areas and stenosis
in hot spots of radiation, indicating a direct link between radiation
and location of coronary stenosis in breast cancer radiotherapy
treatments. These more recent results expanded or confirmed the
findings by other investigators (10, 12–15).
To minimize the potential cardiac toxicities from breast can-
cer radiation treatments, various breath control techniques were
investigated for their control of the heart doses received in the
breast radiation treatments (16–19). The breath-hold and breath-
ing gating techniques have been demonstrated and clinically
implemented to reduce the heart doses and irradiated cardiac vol-
umes for left-sided breast cancer treatments. Another commonly
adopted method is direct block of heart in the radiation treatment
fields of breast (Figure 1). This method can also be used along with
the breath control techniques for some patients if those techniques
are deemed inadequately protecting heart from radiation.
Heart blocks are usually designed based on the heart shapes
outlined on the simulation CT images or directly on the beam’s eye
views of digitally reconstructed radiographs/regular radiographs
of the radiation. However, since heart constantly moves, the heart
outlines captured on the conventional CT images and radiographs
may not reflect the full ranges of the motion. Although 4DCT
may be used to analyze and incorporate the motion in the block
design, it is often too slow to accurately estimate the heart motion.
Furthermore, the heart block inevitably shields some breast tis-
sues, which may require to be irradiated, from radiation, leading
to potential target miss. The question remains on how to opti-
mize a balance between minimal target miss and maximal heart
block while incorporating heart beating motion. This study is to
utilize an in-house developed fluoroscopy image rendering and
registration algorithm to evaluate and optimize the heart block
during left-sided whole breast irradiation treatments. The project
was conducted under an IRB approved protocol.
MATERIALS AND METHODS
For left-sided breast cancer radiation treatments that require heart
blocks, due to the nature of potential heart movement, the fluo-
roscopy imaging modality of the On-Board-Imaging (OBI) system
equipped to linear accelerators can be used to dynamically check
the appropriateness of the heart block designs at treatment. Ten
patients were randomly selected from a pool of left-sided breast
cancer patients who would receive the whole breast irradiation
and required heart blocks. The whole breast treatments, using two
opposed tangential fields, were planned based on 4DCT simula-
tion images. In the plans, the heart blocks were manually designed
and shaped with MLCs (Millennium 120 MLC, Varian Medical
Systems, Palo Alto, CA, USA). The heart block designs took the
considerations of heart locations on the 4DCT and clinical evalu-
ation of the blocked breast tissues. For the 10 patients included in
this study, the heart blocks were all such designed so that the block
edges covered the heart borders reflected on the 4DCT average
image sets.
Using an OBI system equipped to a Varian Linac, beam-
eye viewed fluoroscopy images (for a duration of 10–15 s) were
FIGURE 1 | An example of direct heart block in a tangential field of a
whole breast radiation treatment. The red lines are the field edges and
the blue line is the heart outline on the side of the field in the beam’s eye
view.
acquired for each of the treatment beams after patient treat-
ment setup, and the MLC heart blocks were overlaid onto the
fluoroscopy images with an in-house software package. A non-
rigid image registration and tracking algorithm was utilized to
track the cardiac motion on the fluoroscopy images with minimal
delineation for initialization, and the tracked cardiac motion infor-
mation was used to optimize the heart block design to minimize
the radiation damage to heart while avoiding the over-shielding
that may lead to underdosing certain breast tissues. To be con-
sistent with the principle of heart block design in plans, the
fluoroscopy-based heart block optimization was achieved when
the MLC edges were adjusted to cover the heart borders imaged
on the fluoroscopy.
A brief description of the non-rigid image registration and
tracking algorithm as well as the MLC shape optimization
principle is presented as follows.
MOTION MODELING
Patient heart was initially delineated in fluoroscopy using the com-
bination of CT to fluoroscopy image registration and was manually
adjusted on the first frame of the fluoroscopy. The heart motion
was then dynamically tracked in fluoroscopy using the registration
propagation algorithm as briefly described below.
Given the initial heart delineation C, the registration between
two fluoroscopy frames is based on an enhanced Demons algo-
rithm, which uses the following equation of active force at point
i ∈C :
Ef di = (mi − si)
×
 E∇si∥∥∥ E∇si∥∥∥2 + a2(mi − si)2 +
E∇mi∥∥∥ E∇mi∥∥∥2 + a2(mi − si)2

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wherem is the moving (target) frame, s is the static (source) frame,
and a is a weighting parameter that controls the step size in the
deformation. A constraint is defined as another force term
⇀
f ci to
maintain the smoothness of the contour (heart surface).
Ef ci =
1
k
∑k
j=1 fj exp(−
d2ij
σ2
)
where fj is the image force at a neighboring point j on the heart con-
tour,andσ is the size of the neighborhood in which the smoothness
factor will be effective.
The accumulative force driving the deformation can be
expressed as:
Efi = λc Ef ci + λd Ef di ,
where λc and λd are weights for the image force and the
object constraint, respectively. We use empirical values that
λc= 0.25 and λd= 0.75 for the calculation of the overall defor-
mation force in the registration since these two values performed
the best.
To improve the efficiency, the registration is conducted for
cropped regions only. The size of the cropped region is auto-
matically determined based on the delineation of the heart sur-
face. Hierarchy strategy and frequency domain calculation are
used to further speed up the registration process. After the reg-
istration, the motion vector (dx, dy, dz,) between correspond-
ing pixels in different frames is calculated to generate a motion
model so that the displacement at any point i in the heart
contour on any two neighboring fluoroscopy frames can be
expressed as:
(x , y , z)ij = (d ix , d iy , d iz )j ,j+1 + (x , y , z)ij+1,
where (x , y , z)ij+1 and (x , y , z)ij are the positions of the same point
on the heart contour in different fluoroscopy frame j + 1 and j,
respectively. To retrieve the heart motion throughout the fluo-
roscopy, we propagate the registration to get the motion between
any two arbitrary fluoroscopy frames j and k using:
⇀
d jk = (
⇀
d j ,j+1 +
⇀
d j+1,k +
⇀
d j ,k−1 +
⇀
dk−1,k)/2.
The heart wall displacement with regard to the heart position
in the first frame can be determined using the displacement map.
MLC ADJUSTMENT
The tracked cardiac motion was analyzed and taken into account
for the adaptive optimization of the heart block design. The
shape of the heart block was exported from the Eclipse (Varian)
treatment planning system as the MLC file and loaded into our
internally developed software. After the retrieval of heart motion,
the maximal offset between the heart motion inside the treatment
beam and the corresponding MLC leaf position is computed and
used to adjust the MLC position in the original treatment plan to
maintain full heart shielding.
In the heart block MLC position optimization process, if heart
was adequately covered by the planned MLC positions, no MLC
position adjustment was made; if it was found that heart was not
adequately covered by the planned MLC, the MLC positions were
adjusted so that the MLC edges covered the most infiltrating bor-
ders of heart into the corresponding field of radiation detected on
the fluoroscopy images.
The optimized MLC heart blocks were checked for their
appropriateness by an experienced radiation oncologist.
RESULTS
For the 10 patients, 23 sets of fluoroscopy images were acquired on
23 different days of treatment (Table 1). As expected, heart moved
under the influences of both respiratory and cardiac motion. It
was observed that for 16 out of the 23 treatments, heart moved
beyond the planed heart block into treatment fields and MLC had
to be adjusted to fully block heart. The adjustment was made for all
but one patient, whose digital fluoroscopy was available for only
one treatment. The number of the adjusted MLC leaves ranged
from 1 to 16 (mean= 10), and the MLC leaf position adjustment
ranged from 2 to 10 mm (mean= 6 mm). The added heart block
areas ranged from 3 to 1230 mm2 (mean= 331 mm2). The results
are summarized in Table 1.
In the cases investigated in this study, the dose distributions
were recalculated using the updated MLC positions. The dose cov-
erage of the whole breast was compared to that of the original
Table 1 | Summary of heart block adjustments for the investigated
left-sided breast cancer patient whole breast radiation treatments.
Patient No. of
fluoro
taken
Fluoro
No.
Number of
adjusted
MLC leaves
Largest leaf
adjustment
(mm)
Total
adjusted
area (mm2)
A 2 1 0 0.0 0.0
2 7 2.3 45.4
B 2 1 0 0.0 0.0
2 1 3.7 3.1
C 2 1 0 0.0 0.0
2 16 5.6 285.4
D 4 1 10 5.0 171.5
2 7 3.0 61.4
3 12 8.8 347.8
4 12 8.5 369.2
E 4 1 6 2.0 35.1
2 0 0.0 0.0
3 0 0.0 0.0
4 0 0.0 0.0
F 2 1 15 6.3 349.3
2 9 4.8 157.4
G 1 1 0 0.0 0.0
H 2 1 6 3.2 61.8
2 13 9.2 481.9
I 2 1 8 10.3 307.8
2 9 7.0 227.7
J 2 1 16 9.3 1162.0
2 16 9.9 1230.4
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corresponding plan. No significant dose distribution difference
was observed.
DISCUSSIONS AND CONCLUSION
During whole breast radiation treatments, ideally the entire breast
tissues should be irradiated and receive a therapeutic radiation
dose. To minimize potential radiation damages to heart in the left-
sided breast cancer treatments, heart blocks are added and their
addition may compromise the irradiation of some breast tissues
that fall under the blocks. This study only attempted to address the
potential suboptimal heart protection, without trying to address
the optimal balance between heart protection and breast tissue
irradiation.
It is well known that patient organ motion (e.g., heart and res-
piration), in terms of motion frequency and magnitude, is very
likely not exactly reproducible. The revised heart blocks, based on
the fluoroscopy images acquired prior to the treatment, may not
provide complete heart protection during the radiation beam-on
time, if the organs do not exhibit the motion patterns as imaged
on the fluoroscopy.
Dose distributions in the breast tissues, including both absolute
and relative values, vary with beam field sizes. The changes of heart
blocks at treatment will change the dose distributions and may
introduce unexpected effects. As shown in Table 1, the observed
mean area change was a little over 300 mm2. Given that typical
tangential breast field size is over 20,000 mm2, it is reasonable
to assume that for most cases, the heart block adjustment at
treatment will have insignificant impact to the dose distribu-
tions with same machine outputs. However, in certain extreme
cases, the block area change could be as large as over 1200 mm2
(Table 1), the impact on the dose distribution may not be trivial
and may have to be taken into account if the heart block is to be
changed.
The algorithm to track the motion and optimize the heart
block is very fast and takes only a few seconds to complete the
entire process. However, the acquisition of the fluoroscopic images,
which includes rotating machine gantry and image acquisition
itself, can take up to a few minutes. Therefore, the clinical imple-
mentation of the technique may add a few more minutes to the
treatment time.
In conclusion, simulation CT (and 4DCT) based heart block
design may not provide adequate heart protection for all the
fractions in left-sided whole breast radiation treatments. A
fluoroscopy-based method has been developed to adaptively opti-
mize the heart MLC block to achieve optimal heart protection. On
the other hand, additional study needs to be conducted to seek
an optimal balance between protection of heart and assurance of
entire breast tissue irradiation.
AUTHOR NOTE
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